New international research suggests finger-prick blood tests could offer a breakthrough in diagnosing Alzheimer's disease. This technique aims to detect key biomarkers, potentially making diagnosis more cost-effective and less invasive than current methods like brain scans or spinal fluid tests. The study utilized dried blood samples from participants to measure proteins linked to Alzheimer's pathology, offering a more accessible diagnostic tool.